• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 ATTUNE RP TIB BASE SZ 2 CEM; ATTUNE IMPLANT : KNEE TIBIAL TRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 ATTUNE RP TIB BASE SZ 2 CEM; ATTUNE IMPLANT : KNEE TIBIAL TRAY Back to Search Results
Catalog Number 150610002
Medical Device Problem Code Loss of or Failure to Bond (1068)
Health Effect - Clinical Codes Pain (1994); No Code Available (3191)
Date of Event 07/28/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4).Initial reporter occupation: lawyer.(b)(4).If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
Medical records received 17 june 2019 and were reviewed 22 august 2019 for mdr reportability.On (b)(6) 2015, the patient underwent left knee arthroplasty due to osteoarthrosis, pain, and catching.The surgeon reported no intraoperative complications and patient was transferred to recovery in good condition.All attune components, and two smartset cements were utilized in the procedure.On (b)(6) 2017, the patient underwent a left knee revision due to loosening of the tibial component and pain.The surgeon noted the tibial component was grossly loose, he did not specify the interface.He reported the femoral component and the tibia were well fixed.The surgeon reported no intraoperative complications.Depuy smartset cement x 2 were used in the procedure.All other competitor components were utilized.Doi: (b)(6) 2015.Dor: (b)(6) 2017.(lt knee).
 
Additional Manufacturer Narrative
Depuy synthes is submitting this report pursuant to the provision of 21 cfr, part 803.The report may be based on the information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Product complaint #: (b)(4).Investigation summary: the device associated with this report was not received for examination.Depuy synthes considers the investigation closed at this time.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.Device history lot: null.Device history batch: null.Device history review: null.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE RP TIB BASE SZ 2 CEM
Common Device Name
ATTUNE IMPLANT : KNEE TIBIAL TRAY
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
MDR Report Key9047917
Report Number1818910-2019-104539
Device Sequence Number2192731
Product Code NJL
UDI-Device Identifier10603295042563
UDI-Public10603295042563
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P830055
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Device Explanted Year2017
Reporter Type Manufacturer
Report Source other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 08/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2024
Device Catalogue Number150610002
Device Lot Number8038095
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 08/22/2019
Supplement Date Received by Manufacturer10/07/2019
Initial Report FDA Received Date09/13/2019
Supplement Report FDA Received Date10/08/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ATTUNE PS FEM LT SZ 3 CEM; ATTUNE PS RP INSRT SZ3 6MM
Outcome Attributed to Adverse Event Required Intervention;
Patient Age47 YR
-
-